4-amino-3-phenylbutyric acid and Drug Withdrawal Symptoms

4-amino-3-phenylbutyric acid has been researched along with Drug Withdrawal Symptoms in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (18.18)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (27.27)	24.3611
2020's	6 (54.55)	2.80

Authors

Authors	Studies
Cohen, PA; Ellison, RR; Gaufberg, SV; Gerona, R; Travis, JC	1
Holland, A; Murray, A; VanDreese, B	1
Balasanova, AA; Johnson, BE; McDermott, S	1
Leo, RJ; Mash, JE	1
Nagireddy, R; Ravishankar, DA; Sethi, R	1
Doyno, CR; White, CM	1
Friend, SF; Jimenez, B; Joshi, YB; Steiger, LR	1
Hardman, MI; Sprung, J; Weingarten, TN	1
Khan, AY; Magsalin, RM	1
Zharkovskaia, TA; Zharkovskiĭ, AM	1
Danilin, VP; Krylov, EN; Magalif, AIu; Rait, ML	1

Reviews

1 review(s) available for 4-amino-3-phenylbutyric acid and Drug Withdrawal Symptoms

Article	Year
Acute phenibut withdrawal: A comprehensive literature review and illustrative case report. Bosnian journal of basic medical sciences, 2019, May-20, Volume: 19, Issue:2 Topics: Akathisia, Drug-Induced; Baclofen; Cyproheptadine; Dexmedetomidine; Diphenhydramine; GABA-A Receptor Antagonists; GABA-B Receptor Agonists; gamma-Aminobutyric Acid; Haloperidol; Humans; Lorazepam; Male; Melatonin; Neuroleptic Malignant Syndrome; Olanzapine; Receptors, GABA; Substance Withdrawal Syndrome; Substance-Related Disorders; Young Adult	2019

Article

Year

Acute phenibut withdrawal: A comprehensive literature review and illustrative case report.

Bosnian journal of basic medical sciences, 2019, May-20, Volume: 19, Issue:2

Topics: Akathisia, Drug-Induced; Baclofen; Cyproheptadine; Dexmedetomidine; Diphenhydramine; GABA-A Receptor Antagonists; GABA-B Receptor Agonists; gamma-Aminobutyric Acid; Haloperidol; Humans; Lorazepam; Male; Melatonin; Neuroleptic Malignant Syndrome; Olanzapine; Receptors, GABA; Substance Withdrawal Syndrome; Substance-Related Disorders; Young Adult

2019

Other Studies

10 other study(ies) available for 4-amino-3-phenylbutyric acid and Drug Withdrawal Symptoms

Article	Year
Quantity of phenibut in dietary supplements before and after FDA warnings. Clinical toxicology (Philadelphia, Pa.), 2022, Volume: 60, Issue:4 Topics: Alcoholism; Dietary Supplements; gamma-Aminobutyric Acid; Humans; Substance Withdrawal Syndrome; United States; United States Food and Drug Administration	2022
Chronic Phenibut Use: Symptoms, Severe Withdrawal, and Recovery. WMJ : official publication of the State Medical Society of Wisconsin, 2022, Volume: 121, Issue:1 Topics: Adult; Baclofen; gamma-Aminobutyric Acid; Humans; Male; Substance Withdrawal Syndrome	2022
Phenibut and Bromazolam Use Disorders Requiring Hospitalization for Medically Supervised Withdrawal. The primary care companion for CNS disorders, 2022, 07-12, Volume: 24, Issue:4 Topics: gamma-Aminobutyric Acid; Hospitalization; Humans; Opiate Substitution Treatment; Substance Withdrawal Syndrome	2022
Phenibut: A Novel Nootropic With Abuse Potential. The primary care companion for CNS disorders, 2020, Aug-13, Volume: 22, Issue:4 Topics: Adult; gamma-Aminobutyric Acid; Humans; Male; Nootropic Agents; Substance Withdrawal Syndrome; Substance-Related Disorders	2020
Phenibut Dependence and Withdrawal. The primary care companion for CNS disorders, 2021, Feb-18, Volume: 23, Issue:1 Topics: gamma-Aminobutyric Acid; Humans; Substance Withdrawal Syndrome	2021
Sedative-Hypnotic Agents That Impact Gamma-Aminobutyric Acid Receptors: Focus on Flunitrazepam, Gamma-Hydroxybutyric Acid, Phenibut, and Selank. Journal of clinical pharmacology, 2021, Volume: 61 Suppl 2 Topics: Drug Overdose; Flunitrazepam; gamma-Aminobutyric Acid; Humans; Hypnotics and Sedatives; Oligopeptides; Receptors, GABA; Receptors, Metabotropic Glutamate; Substance Withdrawal Syndrome; Substance-Related Disorders	2021
Dissociative Intoxication and Prolonged Withdrawal Associated With Phenibut: A Case Report. Journal of clinical psychopharmacology, 2017, Volume: 37, Issue:4 Topics: Adult; Baclofen; Delirium; GABA Agonists; gamma-Aminobutyric Acid; Humans; Male; Substance Withdrawal Syndrome; Substance-Related Disorders	2017
Withdrawal symptoms after Internet purchase of phenibut (β-phenyl-γ-aminobutyric acid HCl). Journal of clinical psychopharmacology, 2010, Volume: 30, Issue:5 Topics: Anxiety Disorders; gamma-Aminobutyric Acid; Humans; Internet; Male; Substance Withdrawal Syndrome; Young Adult	2010
[Antiabstinent action of fenibut and baclofen on a model of abstinence induced by the benzodiazepine receptor antagonist CGS 8216 in rats receiving diazepam]. Biulleten' eksperimental'noi biologii i meditsiny, 1987, Volume: 103, Issue:6 Topics: Animals; Baclofen; Behavior, Animal; Diazepam; Drug Evaluation, Preclinical; gamma-Aminobutyric Acid; Isoxazoles; Male; Pyrazoles; Rats; Receptors, GABA-A; Substance Withdrawal Syndrome; Tranquilizing Agents	1987
[Effect of fenibut on the nocturnal sleep of patients with the alcoholic abstinence syndrome]. Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1986, Volume: 86, Issue:2 Topics: Adult; Electrodiagnosis; Ethanol; gamma-Aminobutyric Acid; Humans; Middle Aged; Sleep Stages; Sleep Wake Disorders; Substance Withdrawal Syndrome; Tranquilizing Agents	1986